Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 29, 2027

Conditions
Vaso-occlusive Crisis
Interventions
DRUG

Sufentanil

Administration of intranasal sufentanil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER